Altogether, these results further supported the role of SMAD3 in controlling tumor recognition by NK cells through active cooperation with the epigenetic reader BRD4 in regulating inhibitory receptors and NK exhaustion genes. The gene discussed is SMAD3; the disease is neoplasm.